| Net Cash Provided by (Used in) Operating Activities |
$38,948,000 |
USD |
-91% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$38,892,000 |
USD |
89% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
1,000,000,000 |
shares |
100% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
511,048,237 |
shares |
31% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$83,153,000 |
USD |
|
Q1 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$321,299,000 |
USD |
-33% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$198,153,000 |
USD |
63% |
Q1 2025 |
Q1 2025 |
| Additional Paid in Capital |
$7,673,114,000 |
USD |
29% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
$461,416,000 |
USD |
9.3% |
Q3 2024 |
Q3 2024 |